| Id |
Subject |
Object |
Predicate |
Lexical cue |
| T27 |
0-96 |
Sentence |
denotes |
G6PD deficiency is a common and X-linked enzymopathy affecting approximately 400 million people. |
| T28 |
97-193 |
Sentence |
denotes |
G6PD mutations are carried by females, with 90% of males with the genetic defect being affected. |
| T29 |
194-328 |
Sentence |
denotes |
These affected individuals suffer from a hemolytic crisis after being exposed to oxidants or microbes, including coronaviruses [9–11]. |
| T30 |
329-465 |
Sentence |
denotes |
Geographically, G6PD deficiency affects individuals in African, Mediterranean, Southeast, and South Asian, and Latin American countries. |
| T31 |
466-719 |
Sentence |
denotes |
The fact that G6PD deficiency is more common in some European countries, like Italy and Spain along with the fact that these Mediterranean countries are severely affected by COVID-19 pandemic and have high fatality rates may not be coincidental [12,13]. |
| T32 |
720-837 |
Sentence |
denotes |
This raises the spectre that “G6PD deficiency” can be a predisposing factor that causes severe COVID-19 illness [14]. |
| T33 |
838-979 |
Sentence |
denotes |
This review aims to discuss the potential link between G6PD and viral infections including COVID-19 from the standpoint of redox homeostasis. |
| T34 |
980-1083 |
Sentence |
denotes |
The alternative therapies for COVID-19, including antioxidants and anti-aging drugs are also discussed. |
